维普中文期刊产品整合服务

Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases

查看全文 作  者:Winston Hernández-[1]Ceballos;Jacqueline Cordova-[2,3]Gallardo;Nahum Mendez-[3,4]Sanchez 高影响力作者 机构地区:[1]Plan of Combined Studies in Medicine(PECEM-MD/PhD),Faculty of Medicine,National Autonomous University of Mexico,Mexico City,Mexico;[2]Department of Hepatology,Service of Surgery and Obesity Clinic,General Hospital“Dr.Manuel Gea González”,Mexico City,Mexico;[3]Faculty of Medicine.National Autonomous University of Mexico,Mexico City,Mexico;[4]Liver Research Unit,Medica Sur Clinic&Foundation,Mexico City,Mexico高影响力机构 出  处:《Journal of Clinical and Translational Hepatology》索引2021年第9卷第2期,共12页高影响力期刊 摘  要:The gut microbiome plays a key role in the health-disease balance in the human body.Although its composition is unique for each person and tends to remain stable throughout lifetime,it has been shown that certain bacterial patterns may be determining factors in the onset of certain chronic metabolic diseases,such as type 2 diabetes mellitus(T2DM),obesity,metabolic-associated fatty liver disease(MAFLD),and metabolic syndrome.The gut-liver axis embodies the close relationship between the gut and the liver;disturbance of the normal gut microbiota,also known as dysbiosis,may lead to a cascade of mechanisms that modify the epithelial properties and facilitate bacterial translocation.Regulation of gut microbiota is fundamental to maintaining gut integrity,as well as the bile acids composition.In the present review,we summarize the current knowledge regarding the microbiota,bile acids composition and their association with MAFLD,obesity,T2DM and metabolic syndrome. 关 键 词:Metabolic-associated fatty liver disease Metabolic-associated steatohepatitis Gut microbiota Gut-liver axis DYSBIOSIS Bile acids
相关文献

参考文献(97)

引证文献(9)

耦合文献(181)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费